Abstract:TGF-β and related growth factors activate a broad range of cellular responses and play key roles in the pathogenesis of many diseases especially cancer, fibrotic diseases, autoimmune diseases, and parasitic diseases. The activity of the TGF-β-initiated signaling pathway is tightly controlled, for example, through regulation of the key downstream SMAD tumor suppressors. In response to TGF-β, SMADs are phosphorylated, which triggers a series of downstream signaling and gene transcriptional events in the nucleus. To maintain proper levels of activated SMADs, activated SMADs in the nucleus are normally dephosphorylated by nuclear phosphatase PPM1A and then transported back into the cytoplasm. However, it remains elusive how dephosphorylated SMADs are exported out of the nucleus to ensure the completion of the SMAD signaling termination. Objective: To discover and characterize the underlying pathway that completes the step of SMAD signaling termination. Methods: A combinatorial approach using biochemical, cell biological, and developmental methods was used in this study. Cells were manipulated with expression plasmids for various SMADs, PPM1A, and potential nuclear exporter RanBP3. Xenopus embryos were manipulated using standard protocols. The level of phosphorylated SMADs was performed by western blotting. Nuclear export of SMADs was examined by immunofluorescence microscopy, cell lysate fractionation and a novel reporter assay. Protein-protein interaction of SMADs and RanBP3 was assessed by biochemical assays (e.g. IP-Western) or fluorescence assays. Results: We determined the essential function of RanBP3 in selective nuclear export of SMAD2/3 in the TGF-β pathway. RanBP3 directly recognized dephosphorylated SMAD2/3, which results from the activity of nuclear SMAD phosphatase PPM1A; PPM1A enhanced the physical interaction between RanBP3 and SMAD2/3. We clearly demonstrated that RanBP3 mediated nuclear export of SMAD2/3 in a small G protein Ran-dependent manner. Consequently, increased expression of RanBP3 inhibited TGF-β signaling in mammalian cells and Xenopus embryos, and depletion of RanBP3 expression or dominant negative inhibition of RanBP3 enhanced TGF-β-induced anti-proliferative and transcriptional responses. Finally, we have found that RanBP3 itself was phosphorylated in response to mitogenic growth signals and this phosphorylation could fine-tune the function of RanBP3 in exporting SMADs. Conclusion: We have defined a key role for RanBP3 in selectively mediating SMAD nuclear export and terminating TGF-β signaling. Thus, our finding should provide insights into the mechanisms of TGF-β anti-cancer actions. Knowledge gained from these studies will be used to design novel therapeutic strategies for prevention and treatment of human cancer.

Mtmr4 Attenuates Transforming Growth Factor Beta (Tgf Beta) Signaling By Dephosphorylating R-Smads In Endosomes

Myotubularin-related Protein 4 (MTMR4) Attenuates BMP/Dpp Signaling by Dephosphorylation of Smad Proteins

Curcumin Inhibits Transforming Growth Factor-Beta Activity Via Inhibition of Smad Signaling in HK-2 Cells.

Microtubule Binding to Smads May Regulate TGFβ Activity

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling

PPM1A Functions As a Smad Phosphatase to Terminate TGFβ Signaling

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Posttranslational Regulation of Smads

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Post-translational regulation of TGF-β receptor and Smad signaling.

Small C-terminal Domain Phosphatases Dephosphorylate the Regulatory Linker Regions of Smad2 and Smad3 to Enhance Transforming Growth Factor-β Signaling

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

Coupled Actions of PPM1A and RanBP3 Terminate TGFβ/SMAD Tumor Suppressor Functions

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Termination of TGF-β Superfamily Signaling Through SMAD Dephosphorylation—A Functional Genomic View

Regulation of TGF-beta signalling by protein phosphatases.

TSC-22 Promotes Transforming Growth Factor Β-Mediated Cardiac Myofibroblast Differentiation by Antagonizing Smad7 Activity

C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation Via Smad Dephosphorylation*

Suppression of TGF-β/SMAD signaling by an inner nuclear membrane phosphatase complex